The European Commission, with the support of the European Investment Bank, will provide €20 million for the development of nasal sprays designed to protect against respiratory viruses. To this end, the Commission, through its Health Emergency Response and Preparedness Authority (HERA), has signed an investment agreement with Dutch biotech company Leyden Labs. Nasal sprays deliver […]